Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Target Vessel Failure in Saphenous Vein Grafts clinical trials
A small indexed set (1 trial) with no open enrollment listed right now.
Corpus placement: #11,370 of 28,707 conditions by registered trial count.
1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count
Target Vessel Failure in Saphenous Vein Grafts: 1 US clinical trial tracked, none currently recruiting.
Target Vessel Failure in Saphenous Vein Grafts is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Minneapolis Heart Institute Foundation, running 1 of these trials.
Enrollment posture brief
Registry condition target-vessel-failure-in-saphenous-vein-grafts
OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Target Vessel Failure in Saphenous Vein Grafts has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Target Vessel Failure in Saphenous Vein Grafts on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Target Vessel Failure in Saphenous Vein Grafts is recruiting below its size-band peers.
0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
1 total, page 1 of 1
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Target Vessel Failure in Saphenous Vein Grafts records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Target Vessel Failure in Saphenous Vein Grafts trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Target Vessel Failure in Saphenous Vein Grafts page
1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Target Vessel Failure in Saphenous Vein Grafts trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Minneapolis Heart Institute Foundation sponsors the most Target Vessel Failure in Saphenous Vein Grafts trials on record, review their full trial history before evaluating a specific study. See Minneapolis Heart Institute Foundation's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Target Vessel Failure in Saphenous Vein Grafts condition card totals 1 registered trials; most-linked intervention Percutaneous coronary intervention of the native coronary artery with Synergy; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.